New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
05:20 EDTAKERAkers Biosciences announces distribution agreement with Medline
Akers Biosciences announces a distribution agreement for the company's PIFA Heparin/PF4 and PIFA PLUSS PF4 rapid tests with Medline Industries. Under the terms of the agreement, Medline is expected to begin marketing the company's tests to a network of hospitals and surgery centers across the United States immediately.
News For AKER From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 14, 2015
07:17 EDTAKERAkers Biosciences reports Q1 revenue $510K, may not compare to one estimate $2M
May 12, 2015
07:32 EDTAKERAkers Biosciences introduces two new breath tests
Akers Biosciences introduced two new breath tests to the U.S. market from the company's Akers Wellness division at the World Congress on Anti-Aging Medicine in Hollywood, Florida, last week. BreathScan OxiChek and BreathScan KetoChek, together with the Bluetooth-enabled reading device, BreathScan Lync - which synchs via an app on any mobile device - will enable users to monitor trends in critical metabolic processes. The products will provide healthcare professionals, suppliers of nutritional supplements and weight loss plans, as well as health coaches, the ability to more effectively demonstrate, monitor and adjust the efficacy of their products and the progress of their clients. These products may also provide such customers with an opportunity for significant revenue enhancement through distribution for in-office and at-home use of the devices.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use